Triglyceride, nonesterified fatty acids, and prediabetic neuropathy: Role for oxidative-nitrosative stress

Free Radical Biology and Medicine

Volumn 52, Issue 8, 2012, Pages 1255-1263

  Lupachyk, Sergey ^a   Watcho, Pierre ^a   Hasanova, Nailia ^a   Julius, Ulrich ^b   Obrosova, Irina G ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Acipimox; Dslipidemia; Free radicals; Human Schwann cells; Insulin signaling; NAD(P)H oxidase; Nitrotyrosine; Oxidative nitrosative stress; Prediabetic neuropathy; Superoxide; Zucker fatty (fa fa) rat

Indexed keywords

ACIPIMOX; FATTY ACID; INSULIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; TRIACYLGLYCEROL;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DIABETIC NEUROPATHY; DYSLIPIDEMIA; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; HYPOALGESIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; MALE; NITROSATIVE STRESS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PERIPHERAL NERVE; PRIORITY JOURNAL; RAT; SCHWANN CELL; SENSORY NERVE CONDUCTION; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; CELLS, CULTURED; FATTY ACIDS, NONESTERIFIED; MALE; NITROSATION; OXIDATIVE STRESS; PERIPHERAL NERVOUS SYSTEM DISEASES; PREDIABETIC STATE; RATS; RATS, ZUCKER; TRIGLYCERIDES;

RATTUS;

EID: 84857949744     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2012.01.029     Document Type: Article

References (88)

1. Sahin, M.; Karatas, M.; Sahin, M.; Ertugrul, D.; Kulaksizoǧlu, M.; Dogruk, A.; Gokcel, A.; Tutuncu, N. B.; Guvener, N. D.; Kutlu, M. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels. Minerva Endocrinol. 33:289-296; 2008.
2. Huang, T. J.; Price, S. A.; Chilton, L.; Calcutt, N. A.; Tomlinson, D. R.; Verkhratsky, A.; Fernyhough, P. Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type 1 diabetic rats in the presence of sustained hyperglycemia. Diabetes 52:2129-2136; 2003.
3. Toth, C.; Brussee, V.; Zochodne, D. W. Remote neurotrophic support of epidermal nerve fibres in experimental diabetes. Diabetologia 49:1081-1088; 2006.
4. Francis, G.; Martinez, J.; Liu, W.; Nguyen, T.; Ayer, A.; Fine, J.; Zochodne, D.; Hanson, L. R.; Frey II, W. H.; Toth, C. Intranasal insulin ameliorates experimental diabetic neuropathy. Diabetes 58:934-945; 2009.
5. Tesfaye, S.; Chaturvedi, N.; Eaton, S. E.; Ward, J. D.; Manes, C.; Ionescu-Tirgoviste, C.; Witte, D. R.; Fuller, J. H., EURODIAB Prospective Complications Study Group Vascular risk factors and diabetic neuropathy. N. Engl. J. Med. 352:341-350; 2005.
6. Ziegler, D.; Sohr, C. G.; Nourooz-Zadeh, J. Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy. Diabetes Care 27:2178-2183; 2004.
7. Wiggin, T. D.; Sullivan, K. A.; Pop-Busui, R.; Amato, A.; Sima, A. A.; Feldman, E. L. Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes 58:1634-1640; 2009.
8. Sumner, C. J.; Sheth, S.; Griffin, J. W.; Cornblath, D. R.; Polydefkis, M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 60: 108-111; 2003.
9. Smith, A. G.; Singleton, J. R. Impaired glucose tolerance and neuropathy. Neurologist 14:23-29; 2008.
10. Papanas, N.; Vinik, A. I.; Ziegler, D. Neuropathy in prediabetes: does the clock start ticking early? Nat. Rev. Endocrinol. 7:682-690; 2011.
11. Hughes, R. A.; Umapathi, T.; Gray, I. A.; Gregson, N. A.; Noori, M.; Pannala, A. S.; Proteggente, A.; Swan, A. V. A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy. Brain 127:1723-1730; 2004.
12. Dyck, P. J.; Dyck, P. J.; Klein, C. J.; Weigand, S. D. Does impaired glucose metabolism cause polyneuropathy? Review of previous studies and design of a prospective controlled population-based study. Muscle Nerve 36:536-541; 2007.
13. Sparks, L. M.; Xie, H.; Koza, R. A.; Mynatt, R.; Hulver, M. W.; Bray, G. A.; Smith, S. R. A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes 54:1926-1933; 2005.
14. Longo, K. A.; Govek, E. K.; Nolan, A.; McDonagh, T.; Charoenthongtrakul, S.; Giuliana, D. J.; Morgan, K.; Hixon, J.; Zhou, C.; Kelder, B.; Kopchick, J. J.; Saunders, J. O.; Navia, M. A.; Curtis, R.; DiStefano, P. S.; Geddes, B. J. Pharmacologic inhibition of ghrelin receptor signaling is insulin sparing and promotes insulin sensitivity. J. Pharmacol. Exp. Ther. 339:115-124; 2011.
15. Shevalye, H.; Lupachyk, S.; Watcho, P.; Stavniichuk, R.; Khazim, K.; Abboud, H. E.; Obrosova, I.G. Prediabetic Nephropathy as an Early Consequence of theHigh-Calorie/- High-Fat Diet: Relation to Oxidative Stress. Endocrinology 153:1152-1161; 2012.
16. Zawalich, W. S.; Zawalich, K. C.; Kelley, G. G.; Shulman, G. I. Islet phosphoinositide hydrolysis and insulin secretory responses from prediabetic fa/fa ZDF rats. Biochem. Biophys. Res. Commun. 209:974-980; 1995.
17. Zhou, Y. T.; Shimabukuro, M.; Wang, M. Y.; Lee, Y.; Higa, M.; Milburn, J. L.; Newgard, C. B.; Unger, R. H. Role of peroxisome proliferator-activated receptor α in disease of pancreatic β cells. Proc. Natl. Acad. Sci. U. S. A. 95:8898-8903; 1998.
18. Muellenbach, E. A.; Diehl, C. J.; Teachey, M. K.; Lindborg, K. A.; Archuleta, T. L.; Harrell, N. B.; Andersen, G.; Somoza, V.; Hasselwander, O.; Matuschek, M.; Henriksen, E. J. Interactions of the advanced glycation end product inhibitor pyridoxamine and the antioxidant α-lipoic acid on insulin resistance in the obese Zucker rat. Metabolism 57:1465-1472; 2008.
19. Tong, X.; Hou, X.; Jourd'heuil, D.; Weisbrod, R. M.; Cohen, R. A. Upregulation of Nox4 by TGFβ1 oxidizes SERCA and inhibits NO in arterial smooth muscle of the prediabetic Zucker rat. Circ. Res. 107:975-983; 2010.
20. Henriksen, E. J.; Diamond-Stanic, M. K.; Marchionne, E. M. Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic. Biol. Med. 51: 993-999; 2011.
21. Oltman, C. L.; Coppey, L. J.; Gellett, J. S.; Davidson, E. P.; Lund, D. D.; Yorek, M. A. Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats. Am. J. Physiol. Endocrinol. Metab. 289:E113-E122; 2005.
22. Obrosova, I. G.; Ilnytska, O.; Lyzogubov, V. V.; Pavlov, I. A.; Mashtalir, N.; Nadler, J. L.; Drel, V. R. High-fat diet induced neuropathy of pre-diabetes and obesity: effects of "healthy" diet and aldose reductase inhibition. Diabetes 56:2598-2608; 2007.
23. Vincent, A. M.; Hayes, J. M.; McLean, L. L.; Vivekanandan-Giri, A.; Pennathur, S.; Feldman, E. L. Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1. Diabetes 58:2376-2385; 2009.
24. Davidson, E. P.; Coppey, L. J.; Calcutt, N. A.; Oltman, C. L.; Yorek, M. A. Diet-induced obesity in Sprague-Dawley rats causes microvascular and neural dysfunction. Diabetes Metab. Res. Rev. 26:306-318; 2010.
25. Watcho, P.; Stavniichuk, R.; Ribnicky, D. M.; Raskin, I.; Obrosova, I. G. High-fat diet-induced neuropathy of prediabetes and obesity: effect of PMI-5011, an ethanolic extract of Artemisia dracunculus L. Mediators Inflamm. 2010:268547; 2010.
26. Shertzer, H. G.; Schneider, S. N.; Kendig, E. L.; Clegg, D. J.; D'Alessio, D. A.; Genter, M. B. Acetaminophen normalizes glucose homeostasis in mouse models for diabetes. Biochem. Pharmacol. 75:1402-1410; 2008.
27. Hoehn, K. L.; Salmon, A. B.; Hohnen-Behrens, C.; Turner, N.; Hoy, A. J.; Maghzal, G. J.; Stocker, R.; Van Remmen, H.; Kraegen, E. W.; Cooney, G. J.; Richardson, A. R.; James, D. E. Insulin resistance is a cellular antioxidant defense mechanism. Proc. Natl. Acad. Sci. U. S. A. 106:17787-17792; 2009.
28. Kamanna, V. S.; Kashyap, M. L. Mechanism of action of niacin. Am. J. Cardiol. 101: 20B-26B; 2008.
29. Jacobson, E. L.; Kim, H.; Kim, M.; Jacobson, M. K. Niacin: vitamin and antidyslipidemic drug. Subcell. Biochem. 56:37-47; 2012.
30. Ikemura, M.; Nishikawa, M.; Hyoudou, K.; Kobayashi, Y.; Yamashita, F.; Hashida, M. Improvement of insulin resistance by removal of systemic hydrogen peroxide by PEGylated catalase in obese mice. Mol. Pharm. 7:2069-2076; 2010.
31. Elam, M. B.; Hunninghake, D. B.; Davis, K. B.; Garg, R.; Johnson, C.; Egan, D.; Kostis, J. B.; Sheps, D. S.; Brinton, E. A. Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: a randomized trial. Arterial Disease Multiple Intervention Trial. JAMA 284:1263-1270; 2000.
32. Shih, K. C.; Kwok, C. F.; Hwu, C. M.; Hsiao, L. C.; Li, S. H.; Liu, Y. F.; Ho, L. T. Acipimox attenuates hypertriglyceridemia in dyslipidemic noninsulin dependent diabetes mellitus patients without perturbation of insulin sensitivity and glycemic control. Diabetes Res. Clin. Pract. 36:113-119; 1997.
33. Montecucco, F.; Bertolotto, M.; Vuilleumier, N.; Franciosi, U.; Puddu, A.; Minetti, S.; Delrio, A.; Quercioli, A.; Bergamini, E.; Ottonello, L.; Pende, A.; Lenglet, S.; Pelli, G.; Mach, F.; Dallegri, F.; Viviani, G. L. Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome. Am. J. Physiol. Endocrinol. Metab. 300:E681-E690; 2011.
34. Bae, J. H.; Bassenge, E.; Kim, K. B.; Kim, Y. N.; Kim, K. S.; Lee, H. J.; Moon, K. C.; Lee, M. S.; Park, K. Y.; Schwemmer, M. Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress. Atherosclerosis 155:517-523; 2001.
35. Padilla, A.; Descorbeth, M.; Almeyda, A. L.; Payne, K.; De Leon, M. Hyperglycemia magnifies Schwann cell dysfunction and cell death triggered by PA-induced lipotoxicity. Brain Res. 1370:64-79; 2011.
36. Li, F.; Drel, V. R.; Szabó, C.; Stevens, M. J.; Obrosova, I. G. Low-dose poly(ADPribose) polymerase inhibitor-containing combination therapies reverse early peripheral diabetic neuropathy. Diabetes 54:1514-1522; 2005.
37. Obrosova, I. G.; Xu, W.; Lyzogubov, V. V.; Ilnytska, O.; Mashtalir, N.; Vareniuk, I.; Pavlov, I. A.; Zhang, J.; Slusher, B.; Drel, V. R. PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy. Free Radic. Biol. Med. 44:972-981; 2008.
38. Drel, V. R.; Lupachyk, S.; Shevalye, H.; Vareniuk, I.; Xu, W.; Zhang, J.; Delamere, N. A.; Shahidullah, M.; Slusher, B.; Obrosova, I. G. New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-α. Endocrinology 151:2547-2555; 2010.
39. Lupachyk, S.; Shevalye, H.; Maksimchyk, Y.; Drel, V. R.; Obrosova, I. G. PARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4- hydroxynonenal adduct accumulation: correlation with peripheral nerve function. Free Radic. Biol. Med. 50:1400-1409; 2011.
40. Pacher, P.; Beckman, J. S.; Liaudet, L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87:315-424; 2007.
41. Szabó, C.; Ischiropoulos, H.; Radi, R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat. Rev. Drug Discov. 6:662-680; 2007.
42. Szabó, C.; Mabley, J. G.; Moeller, S. M.; Shimanovich, R.; Pacher, P.; Virag, L.; Soriano, F. G.; Van Duzer, J. H.; Williams, W.; Salzman, A. L.; Groves, J. T. Part I. Pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition catalyst. Mol. Med. 8:571-580; 2002.
43. Pacher, P.; Obrosova, I. G.; Mabley, J. G.; Szabó, C. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications: emerging new therapeutical strategies. Curr. Med. Chem. 12:267-275; 2005.
44. Lehmann, H. C.; Höke, A. Schwann cells as a therapeutic target for peripheral neuropathies. CNS Neurol. Disord. Drug Targets 9:801-806; 2010.
45. Obrosova, I. G.; Drel, V. R.; Pacher, P.; Ilnytska, O.; Wang, Z. Q.; Stevens, M. J.; Yorek, M. A. Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited. Diabetes 54:3435-3441; 2005.
46. Stevens, M. J.; Li, F.; Drel, V. R.; Abatan, O. I.; Kim, H.; Burnett, D.; Larkin, D.; Obrosova, I. G. Nicotinamide reverses neurological and neurovascular deficits in streptozotocin diabetic rats. J. Pharmacol. Exp. Ther. 320:458-464; 2007.
47. Askwith, T.; Zeng, W.; Eggo, M. C.; Stevens, M. J. Oxidative stress and dysregulation of the taurine transporter in high-glucose-exposed human Schwann cells: implications for pathogenesis of diabetic neuropathy. Am. J. Physiol. Endocrinol. Metab. 297:620-628; 2009.
48. Stavniichuk, R.; Drel, V. R.; Shevalye, H.; Vareniuk, I.; Stevens, M. J.; Nadler, J. L.; Obrosova, I. G. Role of 12/15-lipoxygenase in nitrosative stress and peripheral prediabetic and diabetic neuropathies. Free Radic. Biol. Med. 49:1036-1045; 2010.
49. Askwith, T.; Zeng, W.; Eggo, M. C.; Stevens, M. J. Taurine reduces nitrosative stress and nitric oxide synthase expression in high glucose-exposed human Schwann cells. Exp. Neurol. 233:154-162; 2012.
50. Drel, V. R.; Xu, W.; Zhang, J.; Kador, P. F.; Ali, T. K.; Shin, J.; Julius, U.; Slusher, B.; El-Remessy, A. B.; Obrosova, I. G. Poly(ADP-ribose) polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats. Invest. Ophthalmol. Vis. Sci. 50:1778-1790; 2009.
51. Fraser, D. A.; Thoen, J.; Rustan, A. C.; Førre,O.; Kjeldsen-Kragh, J. Changes in plasma free fatty acid concentrations in rheumatoid arthritis patients during fasting and their effects upon T-lymphocyte proliferation. Rheumatology (Oxford) 38:948-952; 1999.
52. Kalyanaraman, B.; Darley-Usmar, V.; Davies, K. J.; Dennery, P. A.; Forman, H. J.; Grisham, M. B.; Mann, G. E.; Moore, K.; Roberts II, L. J.; Ischiropoulos, H. Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations. Free Radic. Biol. Med. 52:1-6; 2012.
53. Lan, H.; Cheng, C. C.; Kowalski, T. J.; Pang, L.; Shan, L.; Chuang, C. C.; Jackson, J.; Rojas-Triana, A.; Bober, L.; Liu, L.; Voigt, J.; Orth, P.; Yang, X.; Shipps Jr., G. W.; Hedrick, J. A. Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity. J. Lipid Res. 52: 646-656; 2011.
54. Obrosova, I. G.; Mabley, J. G.; Zsengellér, Z.; Charniauskaya, T.; Abatan, O. I.; Groves, J. T.; Szabó, C. Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst. FASEB J. 19:401-403; 2005.
55. Drel, V. R.; Pacher, P.; Vareniuk, I.; Pavlov, I. A.; Ilnytska, O.; Lyzogubov, V. V.; Bell, S. R.; Groves, J. T.; Obrosova, I. G. Evaluation of the peroxynitrite decomposition catalyst Fe(III) tetra-mesitylporphyrin octasulfonate on peripheral neuropathy in a mouse model of type 1 diabetes. Int. J. Mol. Med. 20:783-792; 2007.
56. Obrosova, I. G.; Drel, V. R.; Oltman, C. L.; Mashtalir, N.; Tibrewala, J.; Groves, J. T.; Yorek, M. A. Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats. Am. J. Physiol. Endocrinol. Metab. 293: E1645-E1655; 2007.
57. Vareniuk, I.; Pavlov, I. A.; Obrosova, I. G. Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-inducedmousemodel of diabetes. Diabetologia 51:2126-2133; 2008.
58. Stavniichuk, R.; Drel, V. R.; Shevalye, H.; Maksimchyk, Y.; Kuchmerovska, T. M.; Nadler, J. L.; Obrosova, I. G. Baicalein alleviates diabetic peripheral neuropathy through inhibition of oxidative-nitrosative stress and p38 MAPK activation. Exp. Neurol. 230:106-113; 2011.
59. Nagamatsu, M.; Nickander, K. K.; Schmelzer, J. D.; Raya, A.; Wittrock, D. A.; Tritschler, H.; Low, P. A. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 18:1160-1167; 1995.
60. Sagara, M.; Satoh, J.; Wada, R.; Yagihashi, S.; Takahashi, K.; Fukuzawa, M.; Muto, G.; Muto, Y.; Toyota, T. Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcysteine. Diabetologia 39: 263-269; 1996.
61. Cameron, N. E.; Cotter, M. A.; Horrobin, D. H.; Tritschler, H. J. Effects of α-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids. Diabetologia 41:390-399; 1998.
62. Cameron, N. E.; Tuck, Z.; McCabe, L.; Cotter, M. A. Effect of the hydroxyl radical scavenger, dimethylthiourea, on peripheral nerve tissue perfusion, conduction velocity and nociception in experimental diabetes. Diabetologia 44:1161-1169; 2001.
63. Coppey, L. J.; Gellett, J. S.; Davidson, E. P.; Dunlap, J. A.; Lund, D. D.; Yorek, M. A. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes 50:1927-1937; 2001.
64. Schmeichel, A. M.; Schmelzer, J. D.; Low, P. A. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes 52:165-171; 2003.
65. Wang, Y.; Schmeichel, A. M.; Iida, H.; Schmelzer, J. D.; Low, P. A. Ischemia-reperfusion injury causes oxidative stress and apoptosis of Schwann cell in acute and chronic experimental diabetic neuropathy. Antioxid. Redox Signal. 7:1513-1520; 2005.
66. Ziegler, D.; Ametov, A.; Barinov, A.; Dyck, P. J.; Gurieva, I.; Low, P. A.; Munzel, U.; Yakhno, N.; Raz, I.; Novosadova, M.; Maus, J.; Samigullin, R. Oral treatment with α-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 29:2365-2370; 2006.
67. Ziegler, D.; Low, P. A.; Litchy, W. J.; Boulton, A. J.; Vinik, A. I.; Freeman, R.; Samigullin, R.; Tritschler, H.; Munzel, U.; Maus, J.; Schütte, K.; Dyck, P. J. Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care 34:2054-2060; 2011.
68. Bierhaus, A.; Haslbeck, K. M.; Humpert, P. M.; Liliensiek, B.; Dehmer, T.; Morcos, M.; Sayed, A. A.; Andrassy, M.; Schiekofer, S.; Schneider, J. G.; Schulz, J. B.; Heuss, D.; Neundörfer, B.; Dierl, S.; Huber, J.; Tritschler, H.; Schmidt, A. M.; Schwaninger, M.; Haering, H. U.; Schleicher, E.; Kasper, M.; Stern, D. M.; Arnold, B.; Nawroth, P. P. Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J. Clin. Invest. 114:1741-1751; 2004.
69. Wada, R.; Yagihashi, S. Role of advanced glycation end products and their receptors in development of diabetic neuropathy. Ann. N. Y. Acad. Sci. 1043:598-604; 2005.
70. Wang, Y.; Schmeichel, A. M.; Iida, H.; Schmelzer, J. D.; Low, P. A. Enhanced inflammatory response via activation of NF-κB in acute experimental diabetic neuropathy subjected to ischemia-reperfusion injury. J. Neurol. Sci. 247:47-52; 2006.
71. Cameron, N. E.; Cotter, M. A. Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor κB pathway. Curr. Drug Targets 9:60-67; 2008.
72. Nukada, H.; McMorran, P. D.; Baba, M.; Ogasawara, S.; Yagihashi, S. Increased susceptibility to ischemia and macrophage activation in STZ-diabetic rat nerve. Brain Res. 1373:172-182; 2011.
73. Haslbeck, K. M.; Schleicher, E.; Bierhaus, A.; Nawroth, P.; Haslbeck, M.; Neundörfer, B.; Heuss, D. The AGE/RAGE/NF-κB pathway may contribute to the pathogenesis of polyneuropathy in impaired glucose tolerance (IGT). Exp. Clin. Endocrinol. Diabetes 113:288-291; 2005.
74. Stevens, M. J.; Obrosova, I.; Cao, X.; Van Huysen, C.; Greene, D. A. Effects of DL-α- lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes 49:1006-1015; 2000.
75. Obrosova, I. G.; Van Huysen, C.; Fathallah, L.; Cao, X.; Stevens, M. J.; Greene, D. A. Evaluation of α(1)-adrenoceptor antagonist on diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense. FASEB J. 14: 1548-1558; 2000.
76. Toth, C.; Rong, L. L.; Yang, C.; Martinez, J.; Song, F.; Ramji, N.; Brussee, V.; Liu, W.; Durand, J.; Nguyen, M. D.; Schmidt, A. M.; Zochodne, D. W. Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy. Diabetes 57:1002-1017; 2008.
77. Chinen, I.; Shimabukuro, M.; Yamakawa, K.; Higa, N.; Matsuzaki, T.; Noguchi, K.; Ueda, S.; Sakanashi, M.; Takasu, N. Vascular lipotoxicity: endothelial dysfunction via fatty-acid-induced reactive oxygen species overproduction in obese Zucker diabetic fatty rats. Endocrinology 148:160-165; 2007.
78. Poduslo, J. F.; Curran, G. L. Increased permeability across the blood-nerve barrier of albumin glycated in vitro and in vivo from patients with diabetic polyneuropathy. Proc. Natl. Acad. Sci. U. S. A. 89:2218-2222; 1992.
79. Schmelzer, J. D.; Zochodne, D. W.; Low, P. A. Ischemic and reperfusion injury of rat peripheral nerve. Proc. Natl. Acad. Sci. U. S. A. 86:1639-1642; 1989.
80. Thornalley, P. J. The potential role of thiamine (vitamin B1) in diabetic complications. Curr. Diabetes Rev. 1:287-298; 2005.
81. Jolivalt, C. G.; Mizisin, L. M.; Nelson, A.; Cunha, J. M.; Ramos, K. M.; Bonke, D.; Calcutt, N. A. B vitamins alleviate indices of neuropathic pain in diabetic rats. Eur. J. Pharmacol. 612:41-47; 2009.
82. Mizukami, H.; Ogasawara, S.; Yamagishi, S.; Takahashi, K.; Yagihashi, S. Methylcobalamin effects on diabetic neuropathy and nerve protein kinase C in rats. Eur. J. Clin. Invest. 41:442-450; 2011.
83. Hotta, N.; Kakuta, H.; Fukasawa, H.; Koh, N.; Sakakibara, F.; Komori, H.; Sakamoto, N. Effect of niceritrol on streptozocin-induced diabetic neuropathy in rats. Diabetes 41:587-591; 1992.
84. Hotta, N.; Nakamura, J.; Kakuta, H.; Fukasawa, H.; Koh, N.; Sakakibara, F.; Mori, K.; Sakamoto, N. Niceritrol prevents the decrease in red blood cell 2,3-diphosphoglycerate and neuropathy in streptozotocin-induced diabetic rats. J. Diabetes Complications 9:133-139; 1995.
85. Hotta, N.; Sugimura, K.; Tsuchida, I.; Sano, T.; Koh, N.; Matsumae, H.; Sakamoto, N. Use of the C64 quantitative tuning fork and the effect of niceritrol in diabetic neuropathy. Clin. Ther. 16:1007-1015; 1994.
86. Nakamura, S.; Li, H.; Adijiang, A.; Pischetsrieder, M.; Niwa, T. Pyridoxal phosphate prevents progression of diabetic nephropathy. Nephrol. Dial. Transplant. 22: 2165-2174; 2007.
87. Karachalias, N.; Babaei-Jadidi, R.; Rabbani, N.; Thornalley, P. J. Increased protein damage in renal glomeruli, retina, nerve, plasma and urine and its prevention by thiamine and benfotiamine therapy in a rat model of diabetes. Diabetologia 53:1506-1516; 2010.
88. Sugimoto, K.; Rashid, I. B.; Shoji, M.; Suda, T.; Yasujima, M. Early changes in insulin receptor signaling and pain sensation in streptozotocin- induced diabetic neuropathy in rats. J. Pain 9:237-245; 2008.